Overview
- 4 inspections across 4 sites are on record.
- 9 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-03-19.
At a glance
Inspections
4
Sites
4
Observations
9
Career since
Dec 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 Mar 2021 | Human Drugs | On file |
| Torrent Pharmaceuticals Limited | 16 Apr 2019 | Human Drugs | On file |
| Granules Pharmaceuticals Inc. | 26 Oct 2018 | Human Drugs | View 483 → |
| Alcami Carolinas Corporation | 15 Dec 2017 | Human Drugs | View 483 → |
Sites inspected
AstraZeneca Pharmaceuticals LPFrederick, United States1 insp.
Torrent Pharmaceuticals LimitedIndrad, India1 insp.
Granules Pharmaceuticals Inc.Chantilly, United States1 insp.
Alcami Carolinas CorporationCharleston, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Viviana Matta1 shared
Jogy George1 shared
Lata C Mathew1 shared
Zhong Li1 shared
Marcus A Ray1 shared
Larry K Hampton1 shared
Full investigator report
Get the verbatim findings behind Zhao Wang's 9 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site